Norway· NO-ID_E6DBCC66-33FE-4271-8836-7C520D256A86
Erleada
A apalutamide product containing apalutamide, registered in Norway by Janssen-Cilag International N.V.. The same ATC class is registered in 15 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Apalutamide is registered in 15 of 19 countries.
Countries holding a registration under ATC L02BB05 (apalutamide), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Apalutamide · ATC L02BB05
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of apalutamide costs, country by country.
Normalised to the WHO defined daily dose (0.24 g), the median price runs from $0.094 in France to $370.27 in Switzerland — a ×3935 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Apalutamide · price per daily dose (0.24 g)
USD · FX 28 Sept 2026
- CH Switzerland$370.27
- FR France$0.094
The record
At a glance
FEST (Norway)- Active substance
- Apalutamide
- Manufacturer
- Janssen-Cilag International N.V.
- Country
- Norway (NO)
- ATC code
- L02BB05
- ATC class
- Apalutamide
- Defined daily dose
- 0.24 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_E6DBCC66-33FE-4271-8836-7C520D256A86
- no_varenummer5254002 x 14NOK 33705.4
- gtin7323281005933
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
670 interactions on record for apalutamide.
Graded by severity as the source publishes them — 244 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Apalutamide · interactions on record
670 records
- 244 severe
- 412 moderate
- 14 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- RolapitantA04AD14severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Apalutamide in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaERLEADAJanssen-Cilag International N.V., Beerse
- SpainERLEADA 240 MG COMPRIMIDOS RECUBIERTOS CON PELICULAJanssen-Cilag International N.V
- United StatesERLEADAJanssen Products, LP
- FranceERLEADA 240 mg, comprimés pelliculésJANSSEN CILAG INTERNATIONAL NV
- BelgiumErleada 240 mgJanssen-Cilag International
- IcelandErleadaJanssen-Cilag International NV*
- NetherlandsErleada 240 mg filmomhulde tablettenJanssen-Cilag International NV
- PolandErleadaJanssen-Cilag International N.V.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Erleada
- Liechtenstein · Erleada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a8cfd657-5eee-4bb3-a8d6-53955090af34 GET /v1/drugs/a8cfd657-5eee-4bb3-a8d6-53955090af34?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett, filmdrasjert",
"source": "fest",
"status": "A",
"atc_name": "Apalutamid",
"merkevare_id": "ID_E6DBCC66-33FE-4271-8836-7C520D256A86",
"name_form_strength": "Erleada tab 240 mg",
"prescription_group": "C"
}See everything about apalutamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.